That's right: Half of HIV positive men who have sex with men (MSM) have HPV-damaged cells that could develop into anal cancer. Anal cancer rates are rising because more HIV+ people are living longer thanks to the new HIV therapies. We estimate that 10% of HIV+ MSM will develop anal cancer in their life time.
The ANCHOR Study has been halted due to treatment’s high success rate.
Treating anal cancer precursor lesions reduces cancer risk for people living with HIV. Click here for the UCSF press release.
Please contact your local ANCHOR site if you have any questions or concerns.